Questions people ask about IgE Allergie Genetik

The genetics of IgE-mediated allergies is complex, involving multiple variants in genes such as FCER1A, IL-4, IL-13, and HLA. These variants are associated with elevated total IgE levels or specific sensitizations, but they explain only a small fraction of individual allergy risk. Genome-wide association studies (GWAS) have identified many weak-effect loci, yet clinical predictive value remains low. Direct-to-consumer DNA tests offering 'allergy risk' scores are not clinically validated and can be misleading. Allergy diagnosis requires a physician's evaluation including symptom history and specific IgE testing (e.g., ImmunoCAP). Genetic testing may serve as supplementary information but should not replace clinical assessment. Evidence is based on population-level associations, not causal or predictive for individuals.